Myhep ALL Tablet contains the active components Sofosbuvir and Velpatasvir.
It is used to treat chronic hepatitis C.
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV).
The treatment duration is often shorter than older treatment regimens.
Successful treatment can significantly reduce liver inflammation and fibrosis caused by HCV infection.
Uses:
To treat chronic hepatitis C (HCV) infection.
Therapeutic Effects:
Sofosbuvir is a direct-acting antiviral drug (DAA) that inhibits the replication of the HCV virus by targeting a specific protein necessary for viral replication.
Velpatasvir is also a DAA that works by blocking the action of another protein involved in the HCV replication process.
Interaction with Other Drugs:
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Myhep ALL tablet, reducing effectiveness or causing undesirable side effects.
Storage:
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
It should not be frozen.
Keep away from children and pets.
How to Consume:
Read the instructions carefully before taking Myhep ALL tablet.
Take as directed by your doctor.
Take with or without food.
If you experience side effects, stop taking them and talk to your doctor.
Safety Advices:
Pregnancy: There is limited information about the safety of Myhep ALL tablet in pregnancy. Consult your doctor about the risks and benefits.
Breastfeeding: There is limited information about the safety of Myhep ALL tablet in breastfeeding. Consult your doctor about the risks and benefits.
Lungs: If you have a chronic lung disease, talk to your doctor about the risks and benefits.
Liver: If you have a chronic liver disease, talk to your doctor about the risks and benefits.
Alcohol: Avoid alcohol consumption during hepatitis C treatment, including Myhep ALL tablet.
Driving: Common side effects include headache, fatigue, and dizziness. If you experience these side effects, refrain from driving or operating heavy machinery until you feel fully alert and capable.
Side Effects:
Serious: Hepatitis B reactivation, severe allergic reactions.
Before initiating treatment, individuals should be screened for hepatitis B virus (HBV) infection due to the risk of HBV reactivation.
Close monitoring of liver function and HBV DNA levels is necessary during and after treatment, particularly for those with a current or prior HBV infection.
Potential drug interactions with other medications should be carefully evaluated, and healthcare providers should be informed about all current medications.
FAQs:
Can Myhep ALL tablet cure hepatitis C in individuals with advanced liver disease or cirrhosis?
Myhep ALL tablet has shown efficacy in treating hepatitis C in individuals with advanced liver disease or compensated cirrhosis. However, the response rate may vary, and close monitoring of liver function is important during and after treatment.
Is it necessary to undergo regular blood tests while on Myhep ALL tablet treatment?
Yes, regular blood tests are typically conducted during Myhep ALL tablet treatment to monitor liver function, viral load, and treatment response.
Can Myhep ALL tablet be used in patients with kidney disease?
Myhep ALL tablet can be used in patients with mild to moderate kidney impairment without dose adjustment. However, patients with severe renal impairment or end-stage renal disease may require dose adjustments or alternative treatment options.
Can Myhep ALL tablet be used in patients with HIV co-infection?
Myhep ALL tablet is effective and safe in individuals with both hepatitis C and HIV co-infection. However, it is important to coordinate treatment with both infectious disease and HIV specialists.
Can Myhep ALL tablet cause weight gain or loss?
Weight gain or loss is not commonly reported as a side effect of Myhep ALL tablet. However, individual responses to medication can vary.
Can Myhep ALL tablet be used in patients with a history of liver transplantation?
Myhep ALL tablet can be used in patients with a history of liver transplantation who have recurrent hepatitis C. However, individual patient factors and the specific post-transplantation period must be considered.
Can Myhep ALL tablet cause any serious side effects?
While Myhep ALL tablet is generally well-tolerated, like any medication, it can potentially cause side effects. Common side effects include headache, fatigue, nausea, and insomnia. Serious side effects are rare but can include severe allergic reactions, changes in heart rate, and liver problems.
